Pharmaceutical composition for treatment and prevention of restenosis
WO2008066298A1
Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same
WO2008066295A1
Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system
WO2008066300A1
Naphthoquinone-based pharmaceutical composition for treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
WO2008066296A1
Pharmaceutical composition containing phenanthrenequinone-based compound for intestine delivery system
WO2008066301A1
Anticancer composition containing naphthoquinone-based compound for intestine delivery system
WO2008066299A1
Pharmaceutical composition for the treatment and prevention of diseases involving impotence
KR20080069732A
Orotate and orotate derivatives of enhancing biosynthesis of hyaluronic acid and/or glycosaminoglycan
WO2007058480A1
Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
CA2770430A1
Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
WO2006004360A1
Method of enhancing the effect of anti cancer drug by inhibition of the activity of ampk
WO2004096244A1
Method of preparing tumor vaccine for the inducement of anti-tumor activity and a pharmaceutical composition containing the same
